Pages that link to "Q42159140"
Jump to navigation
Jump to search
The following pages link to A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. (Q42159140):
Displaying 50 items.
- Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment (Q26995542) (← links)
- MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis (Q27339129) (← links)
- Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome (Q28732385) (← links)
- Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data (Q31020939) (← links)
- Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. (Q33649222) (← links)
- Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis (Q33665990) (← links)
- Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis (Q33693955) (← links)
- Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound (Q33704086) (← links)
- Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. (Q33826259) (← links)
- Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature (Q33868785) (← links)
- A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis (Q33923580) (← links)
- Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis (Q34133158) (← links)
- Graft versus host disease in the bone marrow, liver and thymus humanized mouse model (Q34408266) (← links)
- Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis (Q34486069) (← links)
- Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis (Q34721223) (← links)
- Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. (Q34888501) (← links)
- Revisiting the matricellular concept (Q35233858) (← links)
- Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids (Q35235716) (← links)
- Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis (Q35545185) (← links)
- Application of biomarkers to clinical trials in systemic sclerosis (Q35681874) (← links)
- Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets (Q35952040) (← links)
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients (Q36040200) (← links)
- Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model (Q36384656) (← links)
- Mechanistic biomarkers for clinical decision making in rheumatic diseases (Q36905584) (← links)
- Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis (Q36942366) (← links)
- Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis (Q37022001) (← links)
- Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis (Q37503878) (← links)
- Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity (Q37509808) (← links)
- Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes (Q37673449) (← links)
- Biomarkers in the management of scleroderma: an update (Q37806663) (← links)
- Biomarkers for skin involvement and fibrotic activity in scleroderma (Q37912251) (← links)
- The Role of TGF-β Receptors in Fibrosis (Q38026846) (← links)
- Targeted therapies for systemic sclerosis (Q38097276) (← links)
- Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development (Q38156227) (← links)
- Quantitating skin fibrosis: innovative strategies and their clinical implications (Q38180018) (← links)
- Personalized medicine in systemic sclerosis: facts and promises (Q38206152) (← links)
- Transforming growth factor β--at the centre of systemic sclerosis (Q38241227) (← links)
- Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma (Q38380369) (← links)
- Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course (Q38630663) (← links)
- Fresh Insights into Disease Etiology and the Role of Microbial Pathogens (Q38678292) (← links)
- Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence? (Q38678295) (← links)
- Biomarkers in Scleroderma: Progressing from Association to Clinical Utility (Q38771824) (← links)
- Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis (Q38909742) (← links)
- Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis (Q38956376) (← links)
- Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study. (Q39061366) (← links)
- Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1. (Q39987550) (← links)
- The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis (Q40099352) (← links)
- Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1. (Q40491370) (← links)
- Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis (Q41900693) (← links)
- dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts. (Q41972569) (← links)